Immunogenicity and PK/PD evaluation in biotherapeutic drug development: scientific considerations for bioanalytical methods and data analysis.
about
Clinical Pharmacology and Translational Aspects of Bispecific AntibodiesEvaluating and Reporting the Immunogenicity Impacts for Biological Products--a Clinical Pharmacology PerspectiveBiopharmaceutical Informatics: supporting biologic drug development via molecular modelling and informatics.Assessment of disulfide and hinge modifications in monoclonal antibodiesEvaluation of Multiple Immunoassay Technology Platforms to Select the Anti-Drug Antibody Assay Exhibiting the Most Appropriate Drug and Target Tolerance.Generation of assay positive controls for detection of isotype anti-drug antibodies for immunogenicity monitoring.Novel drug and soluble target tolerant antidrug antibody assay for therapeutic antibodies bearing the P329G mutation.Characterization of labeled reagents in ligand-binding assays by a surface plasmon resonance biosensor.Embedding Raman Tags between Au Nanostar@Nanoshell for Multiplex Immunosensing.Strategic approaches for assessment and minimization of matrix effect in ligand-binding assays.
P2860
Q33648086-4A7941CE-8301-47F6-B8A9-7C95DB542198Q36653930-D89A4380-99FC-4815-BE1A-7CB7AD520443Q38982236-92029FA8-9FDF-4020-8A99-71DE68623C9EQ39041113-E9A2B3EC-5D72-4BA2-9C4A-BE486D3C592AQ42018411-2133EF47-95D4-4351-A5A6-E04E000DC349Q47408496-A9B1CC6C-EE98-4BE6-9445-04BEE2A855E9Q50995227-C3B1646A-3D29-46A0-9FED-31853BA13A3EQ51269786-A4F05624-A840-4976-BD45-E939A0B516DFQ53087386-FF890625-E642-4702-A160-A4EF21E9B798Q54109156-FCA362C9-9F77-4DDF-AB5F-14C36B5C6B1A
P2860
Immunogenicity and PK/PD evaluation in biotherapeutic drug development: scientific considerations for bioanalytical methods and data analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Immunogenicity and PK/PD evalu ...... cal methods and data analysis.
@ast
Immunogenicity and PK/PD evalu ...... cal methods and data analysis.
@en
type
label
Immunogenicity and PK/PD evalu ...... cal methods and data analysis.
@ast
Immunogenicity and PK/PD evalu ...... cal methods and data analysis.
@en
prefLabel
Immunogenicity and PK/PD evalu ...... cal methods and data analysis.
@ast
Immunogenicity and PK/PD evalu ...... cal methods and data analysis.
@en
P2093
P2860
P356
P1433
P1476
Immunogenicity and PK/PD evalu ...... cal methods and data analysis.
@en
P2093
Vibha Jawa
Yow-Ming C Wang
P2860
P356
10.4155/BIO.13.302
P577
2014-01-01T00:00:00Z